A detailed history of Hexagon Capital Partners LLC transactions in Enovis Corp stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 336 shares of ENOV stock, worth $15,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
336
Previous 434 22.58%
Holding current value
$15,681
Previous $19,000 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$40.57 - $48.1 $3,975 - $4,713
-98 Reduced 22.58%
336 $14,000
Q2 2024

Jul 12, 2024

SELL
$44.56 - $62.43 $9,268 - $12,985
-208 Reduced 32.4%
434 $19,000
Q1 2024

Apr 18, 2024

BUY
$55.44 - $63.8 $5,876 - $6,762
106 Added 19.78%
642 $40,000
Q4 2023

Feb 05, 2024

BUY
$43.67 - $57.07 $8,602 - $11,242
197 Added 58.11%
536 $30,000
Q3 2023

Oct 23, 2023

BUY
$51.65 - $65.54 $17,509 - $22,218
339 New
339 $17,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.53B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.